Industry News notes.

The Tide Journal’s industry news: FDA updates, state rules and market shifts affecting research peptides in the USA.

Compliance, Industry News, Quality Assurance, Research

How Research Use Only (RUO) Peptides Are Reshaping the Market in Florida, the Deep South, and the US

State medical boards across the Deep South are cracking down, but the FDA just moved 12 popular peptides off the restricted list. Discover what these 2026 regulatory shifts mean for independent researchers in Florida, Alabama, and Mississippi, and learn how to legally source and verify RUO compounds under federal FD&C Act exemptions.

Read Article →